NU SKIN (NUS) CFO receives 114,706-share Class A stock grant

Rhea-AI Filing Summary

NU SKIN ENTERPRISES, INC. Chief Financial Officer Thomas James D received a grant of 114,706 shares of Class A Common Stock on March 6, 2026. The shares were awarded at a price of $0.00 per share, reflecting a stock grant rather than an open-market purchase.

Following this award, his directly held Class A Common Stock position increased to 267,102 shares. The transaction is coded as a grant, award, or other acquisition, indicating it was part of an equity award arrangement rather than a cash-funded transaction.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Thomas James D

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Grant/Award	Class A Common Stock	114,706	$0.00	--

Holdings After Transaction: Class A Common Stock — 267,102 shares (Direct)

Footnotes (1)

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Thomas James D

(Last) (First) (Middle)

C/O NU SKIN ENTERPRISES, INC.

75 W CENTER STREET

(Street)

PROVO UT 84601

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
NU SKIN ENTERPRISES, INC. [ NUS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/06/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	03/06/2026		A		114,706	A	$0.00	267,102	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Gregory Belliston as Attorney-in-Fact for James D. Thomas	03/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did NUS CFO Thomas James D report in this Form 4 filing?

Thomas James D reported receiving 114,706 shares of NU SKIN Class A Common Stock as a stock grant on March 6, 2026. The shares were awarded at $0.00 per share, increasing his directly held position to a total of 267,102 shares.

Was the NUS insider transaction a stock purchase or a grant?

The transaction was a grant or award of shares, not a market purchase. It is coded as an acquisition via grant, with 114,706 Class A Common Stock shares awarded at $0.00 per share to CFO Thomas James D on March 6, 2026.

How many NUS shares does CFO Thomas James D hold after this transaction?

After the March 6, 2026 award, Thomas James D directly holds 267,102 shares of NU SKIN Class A Common Stock. This total reflects the addition of the 114,706 shares received in the reported grant or award acquisition transaction at $0.00 per share.

What does transaction code "A" mean in this NUS Form 4?

Transaction code "A" in this filing denotes a grant, award, or other acquisition of securities. For NU SKIN CFO Thomas James D, it represents a stock award of 114,706 Class A Common Stock shares, received at no cost on March 6, 2026.

Is the reported NUS insider transaction classified as a buy or sell?

The transaction is classified as an acquisition via grant, not a buy or sell. The Form 4 shows 114,706 Class A Common Stock shares granted to CFO Thomas James D at $0.00 per share, increasing his directly held holdings to 267,102 shares.